Organised by FIP’s Health and Medicines Information Section
Antibiotic resistance (ABR) is an important global health problem, especially in low and middle-income countries. It has been estimated that the economic burden of antimicrobial resistance has led to additional treatment costs that range from US $7 to more than US $28,500 per episode of care in hospitals in the UK.1 Furthermore, the yearly additional cost of antimicrobial resistance to the US health system alone has been estimated at US $21-34 billion, accompanied by more than 8 million additional days in hospital.2 It is possible that the situation in developing nations could be far worse. However, limited studies have been conducted to evaluate the clinical and economic impacts of ABR in those regions. Appropriate antibiotic use in humans and animals is one of the cornerstones of the World Health Organization’s Global Action Plan on Antimicrobial Resistance. Many developing countries are in the process of working on stewardship programmes in order to improve the appropriate use of antibiotics and combat ABR. Many factors, however, including but not limited to poverty, availability of resources, lack of health professionals, social and cultural influences, literacy rates and degree of acceptance, challenge the development and implementation of such programmes. Hence, stewardship programmes may not work in a similar manner in all countries.
The focus of this session will be to review the different interventions implemented globally, highlighting what has been successful, and what has been challenging in different developing countries, with a view to determine intervention components that can be transferred to different settings.
12:30 – 12:35 Introduction by the chairs
13:50 – 13:55 Conclusion by the chairs
13:55 – 14:00 Room refresh
At the end of this session, participants will be able to:
Type of session: Knowledge-based